Helios Towers plc (HTWS.L)
GBp 93.6
(-0.43%)
GBp 93.6
(-0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 147.2 Million | 51.1 Million | 35.9 Million | 59.5 Million | 37.6 Million | 60.94 Million |
| Net Income | -112.2 Million | -162.5 Million | -119.4 Million | -20.9 Million | -74.8 Million | -119.57 Million |
| Depreciation & Amortization | 219 Million | 178.5 Million | 159.8 Million | 148 Million | 147.2 Million | 141.32 Million |
| Deferred income taxes | - | - | -159.5 Million | -142 Million | - | - |
| Stock-based compensation | 3.7 Million | 4.5 Million | 2 Million | 1 Million | 31.2 Million | - |
| Change in working capital | -47.2 Million | -70.5 Million | -25.4 Million | -3.8 Million | -28.4 Million | -16.71 Million |
| Other non-cash items | 174 Million | 101.1 Million | 178.4 Million | 77.2 Million | -6.4 Million | 55.9 Million |
| Investing Cash Flow | -195.8 Million | -381.5 Million | -407.6 Million | -123.5 Million | -113.9 Million | -105.06 Million |
| Investments in PPE | -196.7 Million | -247.8 Million | -170.5 Million | -123.7 Million | -104.4 Million | -106.15 Million |
| Acquisitions | - | -135.6 Million | -238.2 Million | -1.6 Million | -10.6 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.9 Million | 1.9 Million | 1.1 Million | 1.8 Million | 1.1 Million | 1.08 Million |
| Financing Cash Flow | 43.2 Million | -74.6 Million | 474 Million | 271.5 Million | 208.9 Million | 14.57 Million |
| Debt repayment | -87.8 Million | -341 Million | -367.6 Million | -689.8 Million | -44.6 Million | -14.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.7 Million | - |
| Common Stock Issuance | - | - | 138.5 Million | - | 171.6 Million | - |
| Other Financing Activities | -12.1 Million | 266.4 Million | 335.5 Million | 961.3 Million | 37.3 Million | 14.57 Million |
| Accounts receivables | -88.1 Million | -79 Million | -18.1 Million | 21.1 Million | -56 Million | 9.3 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -3.1 Million | -3.3 Million | -1.6 Million | 600 Thousand | 1 Million | -1 Million |
| Other working capital | -5.1 Million | -67.2 Million | -23.8 Million | -4.4 Million | -29.4 Million | -15.7 Million |
| Cash at beginning of period | 119.6 Million | 528.9 Million | 428.7 Million | 221.1 Million | 89 Million | 119.7 Million |
| Cash at end of period | 106.6 Million | 119.6 Million | 528.9 Million | 428.7 Million | 221.1 Million | 88.98 Million |
| Capital Expenditure | -196.7 Million | -247.8 Million | -170.5 Million | -123.7 Million | -104.4 Million | -106.15 Million |
| Effect of forex changes on cash | -7.6 Million | -4.3 Million | -2.1 Million | 100 Thousand | -500 Thousand | -1.16 Million |
| Net cash flow / Change in cash | -13 Million | -409.3 Million | 100.2 Million | 207.6 Million | 132.1 Million | -30.71 Million |
| Free Cash Flow | -49.5 Million | -196.7 Million | -134.6 Million | -64.2 Million | -66.8 Million | -45.21 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.44 Million | -112.2 Million | -47.16 Million | -33.24 Million | -162.5 Million | -40.27 Million |
| Depreciation & Amortization | 53.68 Million | 219 Million | 94.09 Million | 81.98 Million | 178.5 Million | 76.38 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 3.7 Million | - | - | 4.5 Million | - |
| Change in working capital | -22.92 Million | -47.2 Million | -18.85 Million | -18.81 Million | -70.5 Million | -30.56 Million |
| Other non-cash items | 177.1 Million | 174 Million | 239.98 Million | 205.97 Million | 101.1 Million | 202.01 Million |
| Investing Cash Flow | -57.4 Million | -195.8 Million | -83.43 Million | -73.54 Million | -381.5 Million | -208.04 Million |
| Investments in PPE | -58.11 Million | -196.7 Million | -83.43 Million | -73.54 Million | -247.8 Million | -127.54 Million |
| Acquisitions | 711.58 Thousand | - | - | - | -135.6 Million | -80.49 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -3.9 Million | - | - | 1.9 Million | -1.00 |
| Financing Cash Flow | 25.3 Million | 43.2 Million | 11.44 Million | 23.02 Million | -74.6 Million | -53.51 Million |
| Debt repayment | -39.69 Million | -87.8 Million | -23.35 Million | -37.05 Million | -341 Million | -48.84 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -12.1 Million | -11.9 Million | -14.02 Million | 266.4 Million | -4.66 Million |
| Accounts receivables | -42.22 Million | -88.1 Million | -3.49 Million | -66.81 Million | -79 Million | -8.33 Million |
| Accounts payables | 23 Million | - | -12.46 Million | 51.65 Million | - | -23.42 Million |
| Inventory | -790.64 Thousand | -3.1 Million | -2.31 Million | -162.18 Thousand | -3.3 Million | -495.79 Thousand |
| Other working capital | -2.92 Million | -5.1 Million | -583.27 Thousand | -3.48 Million | -67.2 Million | 1.69 Million |
| Cash at beginning of period | 83.62 Million | 119.6 Million | 100.44 Million | 99.42 Million | 528.9 Million | 320.06 Million |
| Cash at end of period | 114.31 Million | 106.6 Million | 83.62 Million | 100.44 Million | 119.6 Million | 99.42 Million |
| Capital Expenditure | -58.11 Million | -196.7 Million | -83.43 Million | -73.54 Million | -247.8 Million | -127.54 Million |
| Effect of forex changes on cash | - | -7.6 Million | -6.43 Million | -5.06 Million | -4.3 Million | 18.4 Million |
| Net cash flow / Change in cash | 30.68 Million | -13 Million | -16.82 Million | 1.01 Million | -409.3 Million | -220.63 Million |
| Free Cash Flow | 5.92 Million | -49.5 Million | -21.83 Million | -16.94 Million | -196.7 Million | -105.02 Million |
FOCUS
BEAT
2215
BIO
KREF
CIM-PB